Work

Phase II study of bipolar androgen therapy (BAT) in men with metastatic castration-resistant prostate cancer (mCRPC) and progression on enzalutamide (enza).

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.5017

Authors: Benjamin A. Teply, Hao Wang, Rana Sullivan, Irina Rifkind, Ashley Bruns, Morgan Decarli, Victoria J. Sinibaldi, Caroline F. Pratz, Jun Luo, Michael Anthony Carducci, Channing Judith Paller, Emmanuel S. Antonarakis, Mario A. Eisenberger, Samuel R. Denmeade

Institutions: Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Sibley Memorial Hospital

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2892234239

Cites:

Cited by: 3

Related to: 10